Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Prime Medicine, Inc. - Common Stock (NQ: PRME ) 2.900 -0.040 (-1.36%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 740,264 Open 2.920 Bid (Size) 2.800 (100) Ask (Size) 2.910 (5) Prev. Close 2.940 Today's Range 2.750 - 2.980 52wk Range 2.560 - 9.770 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates November 12, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine to Participate in Upcoming Investor Conferences November 06, 2024 From Prime Medicine, Inc. Via GlobeNewswire Performance YTD -66.89% -66.89% 1 Month -11.85% -11.85% 3 Month -25.06% -25.06% 6 Month -47.08% -47.08% 1 Year -67.27% -67.27% More News Read More 12 High-Growth Stocks That Could Deliver Parabolic Returns October 28, 2024 Via The Motley Fool Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress October 24, 2024 From Prime Medicine, Inc. Via GlobeNewswire Why I Keep Buying These 14 Incredible Growth Stocks October 16, 2024 Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings October 15, 2024 From Prime Medicine, Inc. Via GlobeNewswire Why Prime Medicine Stock Soared Nearly 12% Higher on Monday September 30, 2024 Via The Motley Fool Dow Dips 300 Points; Emcore Shares Spike Higher September 30, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Intraday Session September 30, 2024 Via Benzinga Crude Oil Moves Higher; Prime Medicine Shares Spike Higher September 30, 2024 Via Benzinga Exposures Fossil Fuels Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday September 30, 2024 Via Benzinga Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline September 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session September 30, 2024 Via Benzinga Prime Medicine Unveils Strategically Focused Pipeline September 30, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies September 30, 2024 From Prime Medicine, Inc. Via GlobeNewswire 2 Growth Stocks That Could Make You Richer August 28, 2024 Via The Motley Fool Prime Medicine to Participate in Upcoming Investor Conferences August 28, 2024 From Prime Medicine, Inc. Via GlobeNewswire PRME Stock Earnings: Prime Medicine Misses EPS for Q2 2024 August 08, 2024 Via InvestorPlace Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates August 08, 2024 From Prime Medicine, Inc. Via GlobeNewswire Prime Medicine to Present at Upcoming Investor Conferences May 30, 2024 From Prime Medicine, Inc. Via GlobeNewswire If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names May 29, 2024 Via InvestorPlace Exposures Product Safety Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio May 25, 2024 Via The Motley Fool Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024 May 17, 2024 Via InvestorPlace Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 May 17, 2024 Via InvestorPlace Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ May 13, 2024 From Prime Medicine, Inc. Via GlobeNewswire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
